Home Orinase 3mg Tablet
Orinase 3mg Tablet – Available in Pakistan
Orinase 3mg Glimepiride Tablet Pack — Oral Hypoglycaemic Blood Sugar Control – View Product Detail
Orinase 3mg Tablet – Available in Pakistan
Orinase 3mg Glimepiride Tablet Pack — Oral Hypoglycaemic Blood Sugar Control – View Product Detail

Orinase 3mg Tablet

Orinase 3mg Tablet contains Glimepiride 3mg, an intermediate-dose sulfonylurea prescribed for Type 2 diabetes mellitus under physician supervision. It controls blood glucose by stimulating insulin secretion and enhancing insulin sensitivity. A valid prescription is required — available at Derma.pk with nationwide delivery across Pakistan.

Sale price Rs. 517

Pay in 3 Installments of

Rs.

198

  • Oxagit Doxazosin 2mg Tablets – Available in Pakistan
    Oxagit Doxazosin 2mg Tablets
    Sale priceRs. 468
  • 20% SA + Clobetasol Ointment – Available in Pakistan
    20% SA + Clobetasol Ointment
    Sale priceRs. 1,110
  • Cholce-D Vitamin D3 200,000 IU IM Injection – Available in Pakistan
    Cholce-D Vitamin D3 200,000 IU IM Injection
    Sale priceRs. 162
Availability: In stock SKU: DRM-GM-0640
Tags: Anti-Diabetic Blood Sugar Control CCL Pharmaceuticals Diabetes Management Diabetes Tablet Glimepiride Insulin Secretagogue Oral Hypoglycaemic Orinase Prescription Medicine Rx Sulfonylurea 2 Diabetes
Orinase 3mg Tablet – Available in Pakistan

Orinase 3mg Tablet

Rs. 517

Orinase 3mg Tablet — Glimepiride for Type 2 Diabetes

Orinase 3mg Tablet contains Glimepiride 3mg, a sulfonylurea oral hypoglycaemic agent prescribed by physicians for the management of Type 2 diabetes mellitus. At this intermediate dose, Glimepiride continues to stimulate insulin secretion from pancreatic beta cells while enhancing peripheral insulin sensitivity, providing effective blood glucose control for patients requiring a step-up from lower doses. Prescription and physician supervision are required.

Benefits

  • Stimulates pancreatic insulin secretion at an intermediate therapeutic dose
  • Enhances peripheral insulin sensitivity to reduce blood glucose
  • Lowers fasting and post-meal blood sugar levels effectively
  • Supports glycaemic targets and HbA1c reduction
  • Once-daily dosing for consistent diabetes management
  • Prescribed when lower doses require titration under medical supervision

How to Use

Take Orinase 3mg exactly as prescribed by your doctor. Typically taken once daily with the first main meal. Swallow whole with water — do not crush unless instructed. Never skip meals after dosing to avoid hypoglycaemia. Monitor blood glucose levels as directed. Valid prescription required — Rx only.

Browse our general medicines or explore essential health products at Derma.pk.

Usage & Benefits
  • Stimulates pancreatic insulin secretion at an intermediate therapeutic dose
  • Enhances peripheral insulin sensitivity for effective glucose uptake
  • Reduces fasting and post-prandial blood glucose levels
  • Supports glycaemic targets and HbA1c reduction
  • Once-daily oral dosing for consistent blood sugar management
  • Suitable when lower Glimepiride doses require titration under medical supervision
How To Use

Take Orinase 3mg Tablet exactly as prescribed by your doctor. Typically taken once daily with the first main meal of the day. Swallow whole with water — do not crush or split unless specifically instructed. Never skip meals after dosing to avoid hypoglycaemia. Monitor blood glucose levels as directed. Store in a cool, dry place away from sunlight.

FAQs

What is Orinase 3mg Tablet used for?

Orinase 3mg contains Glimepiride 3mg, a sulfonylurea for Type 2 diabetes. It lowers blood sugar by stimulating insulin release and improving insulin sensitivity — prescribed when lower doses are insufficient.

Is a prescription required for Orinase 3mg?

Yes. Glimepiride is a prescription-only (Rx) medication. Submit your valid prescription to sales@derma.pk or WhatsApp +92-320-5999650 before ordering.

Why might a doctor prescribe Orinase 3mg instead of a lower dose?

Orinase 3mg may be prescribed when 1mg or 2mg doses are not achieving adequate blood glucose control, as part of a stepwise diabetes management approach under doctor supervision.